Guided Therapeutics, Inc. (GTHP)

Market Cap	6.77M
Revenue (ttm)	79,000
Net Income (ttm)	-5.79M
Shares Out	51.29M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,765
Open	0.125
Previous Close	0.122
Day's Range	0.122 - 0.122
52-Week Range	0.062 - 0.510
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2023

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 1, 1997
• Employees: 6
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2022, GTHP's revenue was $13,000, a decrease of -83.95% compared to the previous year's $81,000. Losses were -$4.97 million, 33.4% more than in 2021.